Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
NCT04292067 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-06-15
Summary
The primary objective of the study aims to compare the biodiversity of intestinal microbiota between spondylarthritis (SPA) or rheumatoid arthritis (RA) patients and healthy volunteers, by microbiota DNA sequencing in order to further and respond the prior results, which suggested that there is a specific dysbiosis for each of the 2 diseases. A comparative analysis will allow to identify the biomarkers of the specific bacteria.
Conditions
- Spondyloarthritis
- Rheumatoid Arthritis
Interventions
- BIOLOGICAL
-
Faecal sampling
Faecal sampling at baseline
- BIOLOGICAL
-
Blood sampling
Blood sampling at baseline
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Maxime BREBAN, MD, PhD · Service de Rhumatologie, Hôpital Ambroise Paré, APHP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-23
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
Countries
- France
Study Locations
More Related Trials
-
Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
NCT00213564 ·Status: COMPLETED
-
Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia
NCT04806867 ·Status: COMPLETED
-
The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment
NCT05654753 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy
NCT04281602 ·Status: UNKNOWN
-
Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis?
NCT02962479 ·Status: UNKNOWN
-
Dosing Flexibility Study in Patients With Rheumatoid Arthritis
NCT00580840 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA
NCT04973787 ·Status: UNKNOWN
-
Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
NCT01443364 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01521923 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor
NCT04530305 ·Status: UNKNOWN
-
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
NCT01198509 ·Status: COMPLETED ·Phase: NA
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
Fecal Microbiota Transplantation in Axial Spondyloarthritis
NCT06451588 ·Status: RECRUITING ·Phase: PHASE2
-
The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis
NCT05290363 ·Status: RECRUITING ·Phase: NA
-
COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs
NCT04530682 ·Status: COMPLETED
-
Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants
NCT04426279 ·Status: TERMINATED
-
Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.
NCT04970550 ·Status: COMPLETED
-
COVID-SErology in Rheumatoid Arthritis (COVID-19)
NCT04407559 ·Status: COMPLETED
-
Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis
NCT01282528 ·Status: UNKNOWN ·Phase: PHASE4
-
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
NCT02288520 ·Status: COMPLETED
-
A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis
NCT00236028 ·Status: COMPLETED ·Phase: PHASE3
-
Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
NCT00269867 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
NCT01061736 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Biomedicines and Bacterial Translocation in Spondyloarthritis
NCT05244109 ·Status: UNKNOWN ·Phase: NA
-
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
NCT03449758 ·Status: COMPLETED ·Phase: PHASE4